Abhay Joshi Revance Therapeutics, Inc. (RVNC) insider trading activity

Abhay Joshi is COO, President of R&D of Revance Therapeutics, Inc.. Currently has a direct ownership of 120,708 shares of RVNC, which is worth approximately $310,219. The most recent transaction as insider was on Mar 15, 2022, when has been sold 2,607 shares (Common Stock) at a price of $15.79 per share, resulting in proceeds of $41,165. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 121K

0% 3M change

0% 12M change

Total Value Held $310,219

Abhay Joshi Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 15 2022	SELL Payment of exercise price or tax liability	$41,165 $15.79 p/Share	2,607 Reduced 2.11%	120,708 Common Stock
Feb 15 2022	SELL Payment of exercise price or tax liability	$67,458 $13.35 p/Share	5,053 Reduced 3.94%	123,315 Common Stock
Mar 15 2021	SELL Payment of exercise price or tax liability	$37,546 $27.73 p/Share	1,354 Reduced 1.04%	128,368 Common Stock
Feb 15 2021	SELL Payment of exercise price or tax liability	$140,447 $28.97 p/Share	4,848 Reduced 3.6%	129,722 Common Stock
Feb 02 2021	BUY Grant, award, or other acquisition	-	22,620 Added 14.39%	134,570 Common Stock
Sep 30 2020	SELL Payment of exercise price or tax liability	$185,583 $25.14 p/Share	7,382 Reduced 6.19%	111,950 Common Stock
Sep 30 2020	BUY Grant, award, or other acquisition	-	17,500 Added 12.79%	119,332 Common Stock

Abhay Joshi

COO, President of R&D

Nashville, TN

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVNC shares.

Notify only if

Value

Insider Trading

Get notified when an Revance Therapeutics, Inc. insider buys or sells RVNC shares.

Notify only if

Operation

Value

Type

News

Receive news related to Revance Therapeutics, Inc.

Track Activities on RVNC

Account